BTK Inhibitor, PCI-32765

2-propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-; Ibrutinib; CRA-032765

White solid

N/A

936563-96-1

No

C₂₅H₂₄N₆O₂

440.5

≥98% by HPLC

DMSO (>80 mg/ml)

Protect from air and light

A potent Bruton's Tyrosine Kinase (BTK) inhibitor

-20 ̊C

gel pack

36 months

MFCD20261150

16126651

Biochemicals

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.